63%
Finnrick rating
#237 of 283 ranked vendors
3 of 8 classifiable tests passed
methodology · Purity focus
Finnrick analysis

Rethel Jinan New Energy Technology has a narrow, current Tirzepatide record that started clean but is now dominated by later identity, purity, and fill failures. Krause results were the stronger early signal, while later BTLabs samples reported 0% purity and 0 mg fill, so the purity-focus picture is dispersed and trending sharply negative despite limited حجم

methodology →
vendor intelligence report
Vendor Intelligence Report: Rethel Jinan New Energy Technology

WHOIS, Chinese-registry searches, and a pre-domain Facebook promotion complicate Rethel’s claimed manufacturer history. The report also traces template-site residue, direct-contact ordering, and missing COA/payment controls.

20 pages4 risk factors assessed2 Jul 2026
read the report
Peptides
#
Peptide
$/MG
Rating
N
1
Tirzepatide
$0.29
63%
8
Contact channels
Rating trend
CUMULATIVE FINNRICK RATING
83%+65%+48%+30%+<30%10 Sept 2025: 75%10 Sept 2025: 76%5 May 2026: 81%15 May 2026: 78%8 Jun 2026: 74%8 Jun 2026: 70%17 Jun 2026: 66%13 Jul 2026: 63%25 Jul 2026: current 63%75%63%Sep 25Jul 26
Rethel Jinan New Energy Technology test history
COA-backed lab tests

About Rethel Jinan New Energy Technology test results from Finnrick

Rethel Jinan New Energy Technology is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 1 peptide and 8 tests, including ratings, observed price signals, recent test dates, and correction history where available.

Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.

The most visible Rethel Jinan New Energy Technology peptides in this dataset are Tirzepatide (8 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.

Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 8 recent tests.

Corrections
No corrections.